| Public consultation on the Strategic Research Agenda | News | | 23.10.2019 |
| Health Industry Associations statement on Horizon Europe | Position papers | | 18.04.2019 |
| Export Manufacturing Waiver for SPCs: a red flag for investment in EU healthcare biotech | Press release | | 20.02.2019 |
| Ronald Jager joins EuropaBio as Healthcare Biotechnology Director | Press release | | 07.09.2016 |
| EuropaBio appoints Ronald Jager as Director for Healthcare Biotechnology | Press release | | 05.09.2016 |
| Brain cell discovery could open doors to targeted cancer therapies | Press release | | 15.04.2014 |
| Advanced Medicinal Therapies - Step Up The Healthcare Revolution Now | Report | Advanced-Therapy Medicinal Products | 21.02.2020 |
| Advanced Therapies - Transforming Medicine | Factsheets | Advanced-Therapy Medicinal Products | 04.07.2019 |
| Joint press release on ATMPs and GMOs in Europe | Press release | Advanced-Therapy Medicinal Products | 27.09.2017 |
| Stem-Cell Treatment for Blindness Moving Through Patient Testing | Press release | Advanced-Therapy Medicinal Products | 16.04.2014 |
| Irish and UK scientists use stem cells to grow red blood cells | Press release | Advanced-Therapy Medicinal Products | 15.04.2014 |
| Chemically synthesized proteins referencing biological medicinal products | Report | Biosimilars | 21.06.2018 |
| EC launches biosimilar medicines Q&A for patients in 23 languages | Press release | Biosimilars | 29.11.2017 |
| EuropaBio's Biosimilar SmPC Recommendations | Position papers | Biosimilars | 06.06.2017 |
| EuropaBio launches recommendations to enhance transparency of biosimilar labels | Press release | Biosimilars | 06.06.2017 |
| Industry Welcomes 3rd EC Workshop on Biosimilars | Press release | Biosimilars | 05.05.2017 |
| EC Initiative Improves Information for Patients on Biosimilars | Press release | Biosimilars | 23.01.2017 |
| Scientific data and clinical decision making – the NOR-SWITCH Study | Press release | Biosimilars | 20.10.2016 |
| The Evolution of Biotechnology: the arrival of biosimilars | Video | Biosimilars | 12.07.2016 |
| Industry Welcomes the EC Workshop on the Uptake of Biosimilars | Press release | Biosimilars | 20.06.2016 |
| Results from the first ever European biosimilars labelling survey | Press release | Biosimilars | 19.04.2016 |
| EU physicians prefer greater detail in the labelling of biosimilars | Press release | Biosimilars | 19.04.2016 |
| Effects of biosimilar competition on price and volume in Europe | Press release | Biosimilars | 16.12.2015 |
| Biosimilars: What's in a name? | Video | Biosimilars | 06.01.2015 |
| ASBM presented results of European physician survey at EuropaBio – ASEBIO Meeting | Press release | Biosimilars | 27.11.2014 |
| EuropaBio launches guide and position paper on biosimilars | Press release | Biosimilars | 06.10.2014 |
| Guide on Biosimilars in Europe | Position papers | Biosimilars | 06.10.2014 |
| EuropaBio Position Paper on Biosimilars in Europe | Position papers | Biosimilars | 06.10.2014 |
| EuropaBio calls for EMA action on labeling of biosimilars | Press release | Biosimilars | 18.09.2014 |
| EuropaBio Statement on Labelling of Biosimilars | Press release | Biosimilars | 15.09.2014 |
| Pan-European survey calls for a shift in policy for biosimilars | Press release | Biosimilars | 18.04.2014 |
| EMA strengthens the biosimilars pathway in Europe | Press release | Biosimilars | 05.11.2013 |
| EuropaBio joins the Alliance for Safe Biologic Medicines | Press release | Biosimilars | 27.06.2013 |
| EC launches Biosimilars Consensus Information Document | Press release | Biosimilars | 19.04.2013 |
| Biotech is Health | Position papers | EU Biotechnology | 12.11.2019 |
| EuropaBio position on germline genome editing | Position papers | Genome editing | 05.11.2019 |
| Joint pharmaceutical industry statement on the Commission’s proposal for a Regulation on health technology assessment (HTA) | Press release | Health Technology Assessment | 22.06.2018 |
| Regulatory and HTA scientific advice for SMEs | Report | Health Technology Assessment | 17.03.2015 |
| The value of industry involvement in HTA | Position papers | Health Technology Assessment | 07.12.2013 |
| Biotech products and HTA | Position papers | Health Technology Assessment | 13.02.2012 |
| Let’s beat cancer with innovation! | Blog | Innovation | 04.02.2020 |
| Strike rare diseases at the root! | Blog | Orphan medicines | 27.02.2020 |
| EuropaBio and EFPIA celebrate the 15th anniversary of the EU Orphan Medicines Regulation | Report | Orphan medicines | 26.05.2015 |
| Our 2020 Vision | Position papers | Orphan medicines | 11.09.2014 |
| Development process of Orphan Medicinal Products | Report | Orphan medicines | 11.09.2014 |
| Access to OMPs remains unfinished despite MOCA Report | Press release | Orphan medicines | 08.05.2013 |
| Rare diseases go beyond borders – so should research and treatment | Press release | Orphan medicines | 28.02.2013 |
| Development process of Orphan Medicines | Report | Orphan medicines | 01.06.2011 |
| Access to personalised medicine is still limited in Europe | Press release | Personalised medicine | 09.07.2015 |
| A wake up call for personalised medicine in Europe | Press release | Personalised medicine | 24.09.2014 |
| Realising the potential of personalised medicine in Europe | White paper | Personalised medicine | 24.09.2014 |
| "Buying Innovative" in the Healthcare Biotech Market in Europe | Report | Public procurement | 10.02.2017 |
| EuropaBio supports UK BIA call to review IP court decision in the US | Position papers | Public procurement | 21.04.2016 |
| Public procurement of biologic medicines | Press release | Public procurement | 29.06.2015 |
| Public procurement of biologic medicines | Position papers | Public procurement | 29.06.2015 |
| EuropaBio updates on COVID-19 | News | Value of Healthcare biotech | 26.03.2020 |
| Clinical Trials and Coronavirus | Blog | Value of Healthcare biotech | 25.03.2020 |
| Biotechnology spearheads the fight against COVID-19 | Blog | Value of Healthcare biotech | 20.03.2020 |
| EuropaBio Patients BioForum - Key Messages | Report | Value of Healthcare biotech | 14.10.2019 |
| Health industries call for a rapid adoption of Horizon Europe, its missions and partnerships | Position papers | Value of Healthcare biotech | 26.11.2018 |
| SPC waiver risks downgrading the EU as a hub for health innovation | Press release | Value of Healthcare biotech | 28.05.2018 |
| Europe's Life Sciences industry reacts to agreed Brexit transition period | Press release | Value of Healthcare biotech | 23.03.2018 |
| European health community issues key questions Article 50 negotiations must answer for patients and public health | Press release | Value of Healthcare biotech | 09.03.2018 |
| Joint Life Science Industry Policy Paper on the Potential Impact of Brexit | Position papers | Value of Healthcare biotech | 14.12.2017 |
| Launching the Joint Life Science Industry Policy Paper on the Potential Impact of Brexit | Press release | Value of Healthcare biotech | 14.12.2017 |
| Industry calls on UK+EU27 to safeguard patients’ access to medicines with transition + cooperation agreement post-Brexit | Press release | Value of Healthcare biotech | 28.11.2017 |
| From Patent to Patient: The importance of IP rewards and incentives | Report | Value of Healthcare biotech | 23.11.2017 |
| EuropaBio statement regarding the re-location of the EMA to Amsterdam | Press release | Value of Healthcare biotech | 20.11.2017 |
| EuropaBio Statement on EU Ombudsman inquiry into EMA pre‐submission activities | Press release | Value of Healthcare biotech | 24.07.2017 |
| Joint Trade Association Letter on Brexit | | Value of Healthcare biotech | 13.07.2017 |
| How healthcare biotech works and benefits patients and society | Video | Value of Healthcare biotech | 05.05.2017 |
| How Healthcare Biotech Benefits Europe’s Economy and Innovation | Video | Value of Healthcare biotech | 30.03.2017 |
| How does Healthcare Biotech Benefit Europe? | Video | Value of Healthcare biotech | 16.03.2017 |
| Statement on the European Parliament report on improving access to medicines | Press release | Value of Healthcare biotech | 03.03.2017 |
| EFPIA, EUCOPE and EuropaBio Statement on EC Off-Label Use Study | Press release | Value of Healthcare biotech | 02.03.2017 |
| Welcoming EC Commitment to Off-Patent Biologics Market | Press release | Value of Healthcare biotech | 06.10.2015 |
| Swift EU action needed to ensure biotech sector stays competitive | Press release | Value of Healthcare biotech | 30.09.2015 |
| 50 years of EU Pharma Legislation | Press release | Value of Healthcare biotech | 28.09.2015 |
| Industry complaint against French off-label use law | Press release | Value of Healthcare biotech | 31.08.2015 |
| Industry concern over EU science budget cuts | Press release | Value of Healthcare biotech | 03.06.2015 |
| EMA policy on clinical trial data publication | Press release | Value of Healthcare biotech | 03.10.2014 |
| Valuing Healthcare Biotechnology in Europe | Position papers | Value of Healthcare biotech | 22.07.2014 |
| Funding the EU pharmacovigilance system | Press release | Value of Healthcare biotech | 21.02.2014 |
| Draft EU Clinical Trials Regulation lacks ambition | Press release | Value of Healthcare biotech | 20.12.2013 |
| Trialogue forgets importance of competitive clinical trial authorisation timelines | Press release | Value of Healthcare biotech | 27.11.2013 |
| EuropaBio Healthcare Manifesto 2011 - 2012 | Position papers | Value of Healthcare biotech | 13.01.2011 |
| Get the facts : Patient-centred healthcare systems in Europe: what role for biotech? | Video | Value of Healthcare biotech | 06.11.2009 |
| Christofer Fjellner, MEP, discusses patient-centred healthcare systems in Europe | Video | Value of Healthcare biotech | 03.11.2009 |